blindness from glp 1 Doctor Explains Risk (Should You Be Worried?) NAION and GLP1s: Rare Cause
Description
It is not yet available in the UAE market, but is expected to be available in the UAE soon
The European Medicines Agencys safety committee concluded that semaglutide, the active ingredient in Ozempic, Wegovy, and Rybelsus, may rarely cause non-arteritic anterior ischemic optic neuropathy (NAION)
The rise in the use of GLP1 RA may partly stem from updates in guidelines and more in general due to emerging evidence of cardiorenal benefits of GLP1 RA
While theoretically concerning, existing data suggest that combination agents using glucagon agonism do not produce greater-than-expected contractile muscle loss
Prompt follow up can identify adverse effects early and enable decisive management
